Supriya Lifescience share price
You have to be logged in to add this to Watchlist.- ₹714.45(-4.62%)January 23, 2026 15:28:00 PM IST
- NSE
- BSE
- Vol : 119.14 K (NSE + BSE)Last 20 day avg : 140.13 K
Supriya Lifescience is trading -4.62% lower at Rs 714.45 as compared to its last closing price. Supriya Lifescience has been trading in the price range of 749.35 & 710.40. Supriya Lifescience has given -0.56% in this year & 0.43% in the last 5 days. Supriya Lifescience has TTM P/E ratio 32.12 as compared to the sector P/E of 22.37.There are 1 analysts who have initiated coverage on Supriya Lifescience. There are 0.00 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 50.43 Crores in its last quarter.Listed peers of Supriya Lifescience include Sun Pharmaceutical Industries (-0.24%), Divi's Laboratories (-1.08%), Dr Reddy's Laboratories (1.48%).The Mutual Fund holding in Supriya Lifescience was at 0.67% in 31 Dec 2025. The MF holding has decreased from the last quarter. The FII holding in Supriya Lifescience was at 5.19% in 31 Dec 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Jan 24, 2026, 06:46 AM UTC
- BetaHigh volatility1.25Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.01The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.13Annual dividends as a percentage of the stock price.
- PEG RatioIndicates overvaluation4.46The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | Bearish | 1,630.45 | -0.24 | 3,91,070.72 | 36.24 | 5.77 | 0.92 | 0.50 |
| Divi's Laboratories | Bearish | 6,007.00 | -1.08 | 1,59,244.08 | 78.61 | 11.52 | 0.46 | 0.01 |
| Dr Reddy's Laboratories | Neutral | 1,235.15 | 1.48 | 1,03,084.54 | 18.63 | 3.14 | 0.63 | 2.34 |
| Cipla | Bearish | 1,314.85 | -4.13 | 1,06,175.04 | 22.95 | 3.87 | 0.87 | 0.81 |
| Torrent Pharmaceuticals | Neutral | 3,924.15 | -2.48 | 1,32,927.95 | 67.32 | 17.1 | 0.83 | 17.62 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-11-12 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
| 2025-05-27 | Audited Results & Final Dividend |
| 2025-03-10 | Others |
| 2025-01-24 | Quarterly Results & Others |
- IndustryBiotechnology & Drugs
- ISININE07RO01027
- BSE Code543434
- NSE CodeSUPRIYA
Supriya Lifescience is trading at 714.45 as on Fri Jan 23 2026 09:58:00. This is -4.62% lower as compared to its previous closing price of 749.05.
The market capitalization of Supriya Lifescience is 5719.93 Cr as on Fri Jan 23 2026 09:58:00.
The average broker rating on Supriya Lifescience is Buy. The breakup of analyst rating is given below -
- 0.00 analysts have given a strong buy rating
- 1 analysts have given a buy rating
- 0.00 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Supriya Lifescience is 841.70 whereas the 52 wk low is 556.85
Supriya Lifescience can be analyzed on the following key metrics -
- TTM P/E: 32.12
- Sector P/E: 22.37
- Dividend Yield: 0.13%
- D/E ratio: 0.00
Supriya Lifescience reported a net profit of 187.96 Cr in 2025.
The Mutual Fund Shareholding was 0.67% at the end of 31 Dec 2025.
EQUITY QUICK LINKS
Supriya Lifescience QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.